GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Aarey Drugs & Pharmaceuticals Ltd (BOM:524412) » Definitions » Equity-to-Asset

Aarey Drugs & Pharmaceuticals (BOM:524412) Equity-to-Asset : 0.00 (As of Dec. 2023)


View and export this data going back to 1994. Start your Free Trial

What is Aarey Drugs & Pharmaceuticals Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Aarey Drugs & Pharmaceuticals's Total Stockholders Equity for the quarter that ended in Dec. 2023 was ₹0 Mil. Aarey Drugs & Pharmaceuticals's Total Assets for the quarter that ended in Dec. 2023 was ₹0 Mil.

The historical rank and industry rank for Aarey Drugs & Pharmaceuticals's Equity-to-Asset or its related term are showing as below:

BOM:524412' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.29   Med: 0.47   Max: 0.81
Current: 0.51

During the past 13 years, the highest Equity to Asset Ratio of Aarey Drugs & Pharmaceuticals was 0.81. The lowest was 0.29. And the median was 0.47.

BOM:524412's Equity-to-Asset is ranked worse than
58.82% of 1088 companies
in the Drug Manufacturers industry
Industry Median: 0.59 vs BOM:524412: 0.51

Aarey Drugs & Pharmaceuticals Equity-to-Asset Historical Data

The historical data trend for Aarey Drugs & Pharmaceuticals's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aarey Drugs & Pharmaceuticals Equity-to-Asset Chart

Aarey Drugs & Pharmaceuticals Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Equity-to-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.59 0.48 0.42 0.46 0.40

Aarey Drugs & Pharmaceuticals Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Equity-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 0.40 - 0.51 -

Competitive Comparison of Aarey Drugs & Pharmaceuticals's Equity-to-Asset

For the Drug Manufacturers - Specialty & Generic subindustry, Aarey Drugs & Pharmaceuticals's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Aarey Drugs & Pharmaceuticals's Equity-to-Asset Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Aarey Drugs & Pharmaceuticals's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where Aarey Drugs & Pharmaceuticals's Equity-to-Asset falls into.



Aarey Drugs & Pharmaceuticals Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

Aarey Drugs & Pharmaceuticals's Equity to Asset Ratio for the fiscal year that ended in Mar. 2023 is calculated as

Equity to Asset (A: Mar. 2023 )=Total Stockholders Equity/Total Assets
=1174.084/2913.245
=0.40

Aarey Drugs & Pharmaceuticals's Equity to Asset Ratio for the quarter that ended in Dec. 2023 is calculated as

Equity to Asset (Q: Dec. 2023 )=Total Stockholders Equity/Total Assets
=0/0
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Aarey Drugs & Pharmaceuticals  (BOM:524412) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.


Aarey Drugs & Pharmaceuticals Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of Aarey Drugs & Pharmaceuticals's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Aarey Drugs & Pharmaceuticals (BOM:524412) Business Description

Traded in Other Exchanges
Address
340/348, Narshi Natha Street, 107, Sahakar Bhavan, Masjid, Mumbai, MH, IND, 400 009
Aarey Drugs & Pharmaceuticals Ltd is engaged in bulk drug manufacturing and offers products for industrial applications. The company manufactures active pharmaceutical ingredients, intermediates, and specialty chemicals. It is also involved in the trading of industrial solvents and chemicals. The products offered by the company include N-Methyl urea, Dimethyl urea, Mefenamic acid, Metformin, Doxaphylline, BMD among others. The company principally carries its business operations in India.

Aarey Drugs & Pharmaceuticals (BOM:524412) Headlines

No Headlines